Insider · CIK 0001643071

Pande Atul

CIK 0001643071 Name as filed on the most recent filing

Filed as Pande Atul (32)

35 transaction lines · from 32 filings · filed 2019-06-17 to 2026-07-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-07-24 S, Open-market sale Immunovant, Inc.IMVT 59,700, disposed Open Form 4 filing 0001643071-26-000007
2026-06-26 S, Open-market sale Immunovant, Inc.IMVT 57,015, disposed Open Form 4 filing 0001764013-26-000071
2026-06-15 S, Open-market sale Immunovant, Inc.IMVT 51,030, disposed Open Form 4 filing 0001764013-26-000069
2026-05-20 S, Open-market sale Immunovant, Inc.IMVT 192,000, disposed Open Form 4 filing 0001643071-26-000004
2024-12-02 S, Open-market sale Immunovant, Inc.IMVT 221,185, disposed Open Form 4 filing 0001764013-24-000200
2023-12-01 S, Open-market sale Immunovant, Inc.IMVT 3 lines 490,668, disposed Open Form 4 filing 0001764013-23-000155
2022-09-30 P, Open-market purchase Immunovant, Inc.IMVT 84,000, acquired Open Form 4 filing 0001764013-22-000126
2022-02-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 277,000, disposed Open Form 4 filing 0001593968-22-000362
2022-01-03 S, Open-market sale Karuna Therapeutics, Inc.KRTX 326,100, disposed Open Form 4 filing 0001593968-22-000017
2021-12-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 319,325, disposed Open Form 4 filing 0001593968-21-002517
2021-11-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 341,675, disposed Open Form 4 filing 0001593968-21-002355
2021-10-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 301,800, disposed Open Form 4 filing 0001593968-21-002217
2021-09-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 294,550, disposed Open Form 4 filing 0001593968-21-002050
2021-08-13 P, Open-market purchase Immunovant, Inc.IMVT 39,900, acquired Open Form 4 filing 0001764013-21-000088
2021-08-02 S, Open-market sale Karuna Therapeutics, Inc.KRTX 285,425, disposed Open Form 4 filing 0001593968-21-001919
2021-07-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 281,650, disposed Open Form 4 filing 0001593968-21-001740
2021-06-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 278,600, disposed Open Form 4 filing 0001593968-21-001490
2021-05-03 S, Open-market sale Karuna Therapeutics, Inc.KRTX 276,525, disposed Open Form 4 filing 0001593968-21-001217
2021-04-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 300,025, disposed Open Form 4 filing 0001593968-21-001217
2021-03-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 313,575, disposed Open Form 4 filing 0001593968-21-000765
2021-02-01 S, Open-market sale Karuna Therapeutics, Inc.KRTX 250,000, disposed Open Form 4 filing 0001593968-21-000271
2020-12-14 S, Open-market sale Karuna Therapeutics, Inc.KRTX 529,345, disposed Open Form 4 filing 0001593968-20-002354
2020-11-24 P, Open-market purchase Sio Gene Therapies Inc.SIOX 23,399, acquired Open Form 4 filing 0001636050-20-000105
2020-11-12 S, Open-market sale Karuna Therapeutics, Inc.KRTX 484,200, disposed Open Form 4 filing 0001593968-20-002188
2020-11-03 S, Open-market sale Karuna Therapeutics, Inc.KRTX 425,000, disposed Open Form 4 filing 0001593968-20-002123
2020-09-16 S, Open-market sale Karuna Therapeutics, Inc.KRTX 425,000, disposed Open Form 4 filing 0001593968-20-001897
2020-08-12 S, Open-market sale Karuna Therapeutics, Inc.KRTX 425,000, disposed Open Form 4 filing 0001593968-20-001751
2020-08-12 S, Open-market sale Karuna Therapeutics, Inc.KRTX 425,000, disposed Open Form 4 filing 0001593968-20-001752
2020-07-13 S, Open-market sale Karuna Therapeutics, Inc.KRTX 477,150, disposed Open Form 4 filing 0001593968-20-001631
2020-07-08 P, Open-market purchase Axovant Gene Therapies Ltd.AXGT 27,290, acquired Open Form 4 filing 0001209191-20-042216
2020-06-12 S, Open-market sale Karuna Therapeutics, Inc.KRTX 466,350, disposed Open Form 4 filing 0001593968-20-001465
2020-03-16 P, Open-market purchase Axovant Gene Therapies Ltd.AXGT 17,844, acquired Open Form 4 filing 0001209191-20-020125
2019-06-14 P, Open-market purchase Axovant Gene Therapies Ltd.AXGT 17,595, acquired Open Form 4 filing 0001209191-19-037522

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 29
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Pande Atul, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001643071

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.